Pharmaceutical Supply Chain Management: Market Analysis 2023-2030

Triton Market Research presents the Global Pharmaceutical Supply Chain Management Market report segmented by Component (Solution [Transportation Management System, Planning and Analytics, Warehouse and Inventory Management System, Procurement and Sourcing, Manufacturing Execution System], Service [Professional Services, Managed Services]), Deployment Mode (On-premise, Cloud-based), and Regional Outlook (North America, Asia-Pacific, Latin America, Middle East and Africa, Europe).

The report further includes the Market Summary, Industry Outlook, Impact of COVID-19, Key Insight, Porter’s Five Forces Analysis, Market Maturity Analysis, Regulatory Framework, Key Buying Impact Analysis, Key Market Strategies, Drivers, Challenges, Opportunities, Competitive Landscape, Research Methodology & Scope, Global Market Size, Forecasts & Analysis (2023-2030).

According to Triton’s research report, the global pharmaceutical supply chain management market is anticipated to witness revenue growth at a CAGR of 8.70% during the forecast period 2023-2030.

Pharmaceutical supply chain management involves planning, implementing, and monitoring processes that ensure efficient and reliable distribution of pharmaceutical products from manufacturing to delivery while ensuring quality and regulatory compliance.

The market’s expansion is supported by the rising adoption of cloud computing systems, growing emphasis on reducing healthcare expenditure, and increasing demands for pharmaceutical products. The rising demand for healthcare products reflects the increasing need for medicines and healthcare solutions due to population growth and aging demographics. These factors are expected to boost medication utilization, thereby driving the pharmaceutical supply chain management market’s growth.

However, privacy concerns within vulnerable SCM links and technical challenges in software restrict the pharmaceutical supply chain management market’s development.

The Asia-Pacific is estimated to emerge as the fastest-growing region over the forecast period. A significant majority, about 96.1%, of the region’s population now has access to 3G signals, while 94.2% can use mobile broadband signals of long-term evolution (LTE). This expanded use of the internet and mobile devices has facilitated pharmaceutical manufacturers' adoption of supply chain management software and other key business tools. The robust technological infrastructure has thus provided a solid foundation for the Asia-Pacific pharmaceutical supply chain management market.

The notable companies in the pharmaceutical supply chain management market include Manhattan Associates Inc, Infor, Oracle Corporation, Cardinal Health Inc, McKesson Corporation, Tecsys Inc, SAP SE, Jump Technologies Inc, Terso Solutions Inc, and Arvato Group.

An important development in supply chain management (SCM) is the enhancement of supply chain visibility (SCV) to display real-time activity occurring within the supply chain. This feature is invaluable in the event of disruptions, providing decision-makers with critical information before advanced technologies such as big data analytics are integrated into SCM. Through this integration, companies can maintain closer relationships with their suppliers, build more comprehensive supplier profiles, and even uncover opportunities for business expansion.